Yes, weight gain can occur during tirzepatide treatment, despite the medication's mechanism to reduce appetite and improve metabolic function
Microdosing creates new, hard-to-predict hazards that clinical trials are designed to detect, and the small size of the dose does not eliminate the chance of serious harm
The AAOS is the trusted leader in advancing musculoskeletal health
Neuropathies with prolonged conduction block, single and grouped fasciculations, localized limb myokymia
In the lung, GSTT1 helps clear reactive epoxides and aldehydes from tobacco smoke and polluted air, which can otherwise damage airway cells and contribute to chronic obstructive pulmonary disease and lung cancer risk in the context of heavy exposure
This philosophy guides every aspect of our service, from your initial consultation to ongoing support